Established in 2020 Wednesday, March 27, 2024


Five or six doses? Controversy over Pfizer vaccine vials
A picture taken on January 7, 2021 shows a vial and a syringe of the Pfizer/BioNTech Comirnaty Covid-19 vaccine on January 7, 2021 at the Bordeaux CHU hospital. Mehdi Fedouach / AFP.

by Paul Ricard / Marie-Morgane Le Moel



PARIS (AFP).- The US pharmaceutical giant Pfizer, which is manufacturing the Covid-19 vaccine developed by Germany's BioNTech, now considers each vial contains six doses compared to five previously.

The difficulty in obtaining that sixth dose in practice means many countries are at loggerheads with Pfizer and facing a drop in supply.

How many doses?
Until recently, each vial of the BioNTech-Pfizer vaccine was considered to officially contain five doses.

After being thawed, the contents of each vial are diluted with 1.8 ml of saline solution, creating a total of 2.25 ml of injectable solution. With each dose 0.3 ml, in theory there are just over seven doses.

But theory and practice are different. Medical personnel are unable to measure so precisely the doses to get seven doses they can inject into people.

But the found they could -- with the right equipment -- reliably get six doses out of the vials.

Both EU and US regulators now consider that the vials contain six doses and have authorised the use of the sixth dose.

However the European Medicines Agency noted that this sixth dose depends on the availability of specific syringes.

Doses not vials
Pfizer has revised higher its production target for this year from 1.3 billion doses to 2 billion. While part of that reflects plans to further increase output, it also reflects the effect of the label change on vials.

Pfizer said its contracts specify the delivery of a certain number of vaccine doses and not vials.

This means customers are now receiving fewer vials than they did before regulators approved the change.




'Niche' syringes
But in order to obtain that sixth dose medical a special syringe is required with a low "dead space". The dead space is the amount of the product left in the syringe when the plunger is completely pushed down.

To get the sixth dose of the BioNTech-Pfizer vaccine syringes with very low dead spaces are needed, but medical device manufacturer Becton Dickinson (BD) says there is a supply crunch for them.

"Low dead space syringes are niche products and there has... traditionally been minimal market demand based on health care provider needs," a company spokesman said.

Manufacturing capacity of these syringes is limited and it will take time to boost production.

Many vaccination centres in France have not received low dead space syringes and are finding it difficult to obtain a sixth dose with regular syringes.

If Pfizer delivers fewer vials "we'll vaccinate fewer people than planned" initially, warned Du Cote de la Science, a group of French doctors and researchers who have sought to influence the public debate in France about the pandemic.

Governments on their guard
Pfizer's decision sparked an outcry in Belgium.

Retirement homes hoping to step up their vaccination campaign thanks to using the sixth dose in vials are now receiving fewer vials than initially promised, one director told AFP.

Sweden's health authority has demanded an explanation from Pfizer, but has so far not frozen its payments.

France's health ministry has launched an effort to acquire the necessary syringes and developed training materials to help medical personnel learn the method to obtain the sixth dose.

The European Commission says it has already launched a joint supply initiative that should allow member states to buy the necessary syringes.

© Agence France-Presse







Today's News

January 28, 2021

Models suggest galactic collisions can starve massive black holes

Regeneron works on UK, S.African Covid variants: company

A little soap simplifies making 2D nanoflakes

Micro-brewing goes more micro

Five or six doses? Controversy over Pfizer vaccine vials

Purported phosphine on Venus more likely to be ordinary sulfur dioxide, new study shows

Genetically modified mosquitoes key to stopping Zika virus spread

Scientists jump-start two people's brains after coma

Ultra-absorptive nanofiber swabs could improve SARS-CoV-2 test sensitivity

Genome-editing tool TALEN outperforms CRISPR-Cas9 in tightly packed DNA

Dramatic shark decline leaves 'gaping hole' in ocean: study

Scientists reveal dynamic mechanism of lead-free quadruple perovskite nanocrystals

Major discovery helps explain coral bleaching

Oceans warmed steadily over 12,000 years: study

A protein that can melt tumors discovered at Vanderbilt

New research on carbon cracks open secrets deep inside exoplanets

MU Research Reactor to supply radioisotope for targeted cancer therapy

Juicing technique could influence healthfulness of fresh-squeezed juice

A mild way to upcycle plastics used in bottles into fuel and other high-value products



 


Editor & Publisher: Jose Villarreal
Art Director: Juan José Sepúlveda Ramírez



Tell a Friend
Dear User, please complete the form below in order to recommend the ResearchNews newsletter to someone you know.
Please complete all fields marked *.
Sending Mail
Sending Successful